Effective April 1, 2022, Mr. Hosseinion was appointed as President of the Company and A Director. He has served as Chief Executive Officer of Clinigence Holdings, Inc. since February 26, 2021, and a Chairman of the Board for Clinigence Holdings, Inc. since April 2019. He is a Co-Founder of Apollo Medical Holdings, Inc. (Nasdaq: AMEH) and has served as a member of the Board of Directors of Apollo Medical Holdings, Inc. since July 2008. He also served as the Chief Executive Officer of Apollo Medical Holdings, Inc. from July 2008 to December 2017, and the Co-Chief Executive Officer of Apollo Medical Holdings, Inc. from December 2017 to March 2019. And in 2001, Dr. Hosseinion co-founded ApolloMed Hospitalists.
Dr. Hosseinion received his B.S. in Biology from the University of San Francisco and his M.S. in Physiology and Biophysics from the Georgetown University Graduate School of Arts and Sciences. He earned his Medical Degree from the Georgetown University School of Medicine and completed his residency in internal medicine at the Los Angeles County-University of Southern California Medical Center.
Dr. Hosseinion’s qualifications to serve on our Board of Directors include his position as our Chief Executive Officer of the Company. In addition, Dr. Hosseinion's experience as a physician, along with his background at Apollo Medical Holdings, Inc., brings to our Company and Board of Directors a depth of understanding of physician culture and the healthcare market, as well as a strong knowledge of the public markets.